tiprankstipranks
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
US Market
BBIO
BridgeBio Pharma
RESEARCH TOOLSreports

BridgeBio Pharma (BBIO) Stock News & Sentiment

1,460 Followers
BridgeBio: Advancing First-in-Class LGMD Therapy and Blockbuster ATTR Franchise Underpin Reiterated Buy and $100 Target
Premium
Ratings
BridgeBio: Advancing First-in-Class LGMD Therapy and Blockbuster ATTR Franchise Underpin Reiterated Buy and $100 Target
12d ago
BBIO
BridgeBio Files NDA for LGMD2I/R9 Oral Therapy
Premium
Company Announcements
BridgeBio Files NDA for LGMD2I/R9 Oral Therapy
12d ago
8K
BBIO
Buy Rating on BridgeBio: Differentiated Rare-Disease Portfolio and Clear Path to Profitability Support Robust Long-Term Growth
Premium
Ratings
Buy Rating on BridgeBio: Differentiated Rare-Disease Portfolio and Clear Path to Profitability Support Robust Long-Term Growth
26d ago
BBIO
BridgeBio Pharma: Advancing Late-Stage Pipeline and Near-Term Catalysts Underpin Reaffirmed Buy and $100 Target
Premium
Ratings
BridgeBio Pharma: Advancing Late-Stage Pipeline and Near-Term Catalysts Underpin Reaffirmed Buy and $100 Target
1M ago
BBIO
BridgeBio Pharma Earnings Call Signals Profitable Pivot
Premium
Company Announcements
BridgeBio Pharma Earnings Call Signals Profitable Pivot
2M ago
BBIO
BridgeBio Pharma: Clear Path to 2027 Profitability with Underappreciated Pipeline Upside
Premium
Ratings
BridgeBio Pharma: Clear Path to 2027 Profitability with Underappreciated Pipeline Upside
2M ago
BBIO
BridgeBio: Robust Attruby Launch and Late-Stage Pipeline Support Buy Rating and Path to Sustainable Cash Generation
Premium
Ratings
BridgeBio: Robust Attruby Launch and Late-Stage Pipeline Support Buy Rating and Path to Sustainable Cash Generation
2M ago
BBIO
More BBIO News >

BBIO News on the Web

Why BridgeBio Pharma Shares Are Sliding Today
TipRanks News
Bearish
Texas Instruments upgraded, Circle downgraded: Wall Street’s top analyst calls
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: DaVita (DVA), BridgeBio Pharma (BBIO) and Becton Dickinson (BDX)
TipRanks News
Neutral
BridgeBio initiated with an Outperform at RBC Capital
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO)
TipRanks News
Bullish
Piper Sandler Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)
TipRanks News
Neutral
BridgeBio: Advancing First-in-Class LGMD Therapy and Blockbuster ATTR Franchise Underpin Reiterated Buy and $100 Target
TipRanks News
Neutral
BridgeBio Files NDA for LGMD2I/R9 Oral Therapy
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
BBIO
Sector Average
Media Buzz
This Week4 articles
Weekly Average3.75 articles
News Sentiment
This Week0%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BBIO’s Media Buzz Sentiment?
4 articles about BBIO were published this week. In an average week, 3.75 articles are published.
    What is BBIO’s weekly average amount of articles?
    In an average week, 3.75 articles about BBIO are published.
      What is BBIO’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      AORTArtivion
      NBIXNeurocrine
      STAAStaar Surgical
      SLPSimulations Plus
      OWLTOwlet
      Showing the stocks with the most bullish news sentiment over the past week